Skip to content
The GLP-1 Verdict
Menu
Ranked #95 · Grade C

Amble review

Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

Visit Amble Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $179/mo (starting dose, compounded)
Tirzepatide
From $289/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only

The scorecard

Amble scored on our six published factors. See the methodology.

Real-world results75/100
Price honesty64/100
Prescriber access90/100
Formulary choice82/100
Cancellation fairness56/100
Member support70/100

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The verdict

Best for: Shoppers who want mainstream telehealth GLP-1 access. Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

Ranked #95 of 499 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. On the board it sits between AmberHealth, 73/100 above and Corsica Health at 73/100 below, with the GOAL.MD ruling the next one down.

If that ruling leaves you undecided, the 7 programmes we rank against Amble are graded on the same six factors and listed in score order. We have also ruled on it directly: CoreAge Rx vs Amble goes to CoreAge Rx, 94/100 to 73/100.

Visit Amble

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Amble's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Amble's site. Not medical advice; see our disclosure.

← Back to all rankings